Dr. Mauro Gargiulo: revolutionising EVAR with CO2 angiography

In this exclusive PVI 2024 interview, Dr. Mauro Gargiulo highlights the key benefits of CO2 angiography in the endovascular treatment of aortic disease. This innovative technique, set to become a standard in clinical practice, offers significant advantages, including reduced contrast media usage and a lower risk of acute kidney injury during and after endovascular aortic repairs.

CO2 angiography also enhances procedural precision by improving the detection of type 1, 2, and 3 endoleaks, ensuring optimal treatment quality. Additionally, it helps accurately define landing zones for endograft placement, with some limitations in proximal segments. Already tested in FEVAR and BEVAR procedures, this approach provides clear visualisation of the celiac trunk, SMA, and renal vessels, further expanding its clinical applications.

Discover how CO2 angiography is shaping the future of EVAR—watch the full interview now!